Senior Account Executive Enterprise / Sales Lead (m/f/x)
About the role
As a Senior Account Executive Enterprise / Sales Lead at osapiens, you will play a pivotal role in driving our clients' success through strategic account management and sales initiatives. You will be responsible for managing high-value accounts, developing long-term relationships, and achieving ambitious sales targets.
WHAT YOU’LL OWN
- Manage and grow key enterprise accounts, ensuring customer satisfaction and loyalty.
- Develop and execute comprehensive sales strategies tailored to each client’s needs.
- Collaborate with cross-functional teams to deliver integrated solutions that meet business objectives.
- Build strong relationships with clients, partners, and stakeholders to foster mutual success.
- Stay updated on industry trends and competitive landscape to inform sales decisions.
WHAT YOU’LL BRING
- A proven track record of success in enterprise sales or a related field.
- Exceptional interpersonal and communication skills, with the ability to build and maintain strong relationships.
- Strong problem-solving and analytical skills to navigate complex sales scenarios.
- Experience in managing multiple accounts and prioritizing tasks effectively.
- Ability to work independently and as part of a team, with a proactive approach to meeting goals.
- Passion for sustainability and ethical business practices, aligning with osapiens’ values.
About osapiens
osapiens develops holistic Software-as-a-Service solutions that help global companies ensure transparency, efficiency, and trust across their entire value chain. Through its cloud platform, the osapiens HUB, the company leverages innovative technologies, including artificial intelligence, to strengthen businesses while promoting human rights, ecological responsibility, and sustainable corporate governance.
Founded in 2018 and headquartered in Mannheim, Germany, osapiens works with around 2,500 companies in over 50 countries across industries such as consumer goods, automotive, fashion, pharmaceuticals, and medical products. The company is backed by Goldman Sachs and Decarbonization Partners, reinforcing its commitment to responsible, sustainable growth and has reached unicorn status in January 2026.